Myocardial Edema, Myocyte Injury, and Disease Severity in Fabry Disease.


Journal

Circulation. Cardiovascular imaging
ISSN: 1942-0080
Titre abrégé: Circ Cardiovasc Imaging
Pays: United States
ID NLM: 101479935

Informations de publication

Date de publication:
03 2020
Historique:
entrez: 3 3 2020
pubmed: 3 3 2020
medline: 20 8 2020
Statut: ppublish

Résumé

Background Cardiovascular magnetic resonance can demonstrate myocardial processes in Fabry disease (FD), such as low native T1 (sphingolipid storage) and late gadolinium enhancement (LGE, scar). Recently, high T2 (edema) has been observed in the basal inferolateral wall along with troponin elevation. We hypothesized that edema and myocyte injury would be chronically associated and have electrical, mechanical, and disease associations in FD. Methods A prospective international multicenter study was conducted on 186 consecutive FD patients (45.2±1.1 years, 58% females). Additionally, 28 patients with hypertrophic cardiomyopathy, 30 with chronic myocardial infarction and 59 healthy volunteers were included. All study participants underwent comprehensive cardiovascular magnetic resonance with T1 and T2 mapping, cines, and LGE imaging. Results LGE in the basal inferolateral wall in FD had T2 elevation (FD 58.2±5.0 ms versus hypertrophic cardiomyopathy 55.6±4.3 ms, chronic myocardial infarction 53.7±3.4 ms and healthy volunteers 48.9±2.5 ms,

Identifiants

pubmed: 32114828
doi: 10.1161/CIRCIMAGING.119.010171
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e010171

Subventions

Organisme : British Heart Foundation
ID : FS/18/21/33447
Pays : United Kingdom
Organisme : British Heart Foundation
ID : SP/20/2/34841
Pays : United Kingdom

Auteurs

João B Augusto (JB)

Institute of Cardiovascular Science, University College London, United Kingdom (J.B.A., S.N., M.A., K.K., G.C., T.K., J.C.M.).
Cardiac Imaging Department, Barts Heart Centre, St Bartholomew's Hospital, London, United Kingdom (J.B.A., S.N., H.B., M.A., K.K., J.C.M.).

Sabrina Nordin (S)

Institute of Cardiovascular Science, University College London, United Kingdom (J.B.A., S.N., M.A., K.K., G.C., T.K., J.C.M.).
Cardiac Imaging Department, Barts Heart Centre, St Bartholomew's Hospital, London, United Kingdom (J.B.A., S.N., H.B., M.A., K.K., J.C.M.).

Ravi Vijapurapu (R)

Cardiology Department (R.V., S.B., R.P.S.), University Hospitals Birmingham, United Kingdom.

Shanat Baig (S)

Cardiology Department (R.V., S.B., R.P.S.), University Hospitals Birmingham, United Kingdom.

Heerajnarain Bulluck (H)

Cardiac Imaging Department, Barts Heart Centre, St Bartholomew's Hospital, London, United Kingdom (J.B.A., S.N., H.B., M.A., K.K., J.C.M.).
Hatter Cardiovascular Institute, London, United Kingdom (H.B.).

Silvia Castelletti (S)

Istituto Auxologico Italiano IRCCS Center for the Cardiac Arrhythmias of Genetic Origin, Milan, Italy (S.C.).

Mashael Alfarih (M)

Institute of Cardiovascular Science, University College London, United Kingdom (J.B.A., S.N., M.A., K.K., G.C., T.K., J.C.M.).
Cardiac Imaging Department, Barts Heart Centre, St Bartholomew's Hospital, London, United Kingdom (J.B.A., S.N., H.B., M.A., K.K., J.C.M.).

Kristopher Knott (K)

Institute of Cardiovascular Science, University College London, United Kingdom (J.B.A., S.N., M.A., K.K., G.C., T.K., J.C.M.).
Cardiac Imaging Department, Barts Heart Centre, St Bartholomew's Hospital, London, United Kingdom (J.B.A., S.N., H.B., M.A., K.K., J.C.M.).

Gabriella Captur (G)

Institute of Cardiovascular Science, University College London, United Kingdom (J.B.A., S.N., M.A., K.K., G.C., T.K., J.C.M.).

Tushar Kotecha (T)

Institute of Cardiovascular Science, University College London, United Kingdom (J.B.A., S.N., M.A., K.K., G.C., T.K., J.C.M.).
Royal Free London NHS Foundation Trust and University College London, United Kingdom (T.K., U.R., M.F., D.H.).

Uma Ramaswami (U)

Royal Free London NHS Foundation Trust and University College London, United Kingdom (T.K., U.R., M.F., D.H.).

Michel Tchan (M)

Department of Genetic Medicine, Westmead Hospital, Sydney, Australia (M.T.).

Tarekegn Geberhiwot (T)

Inherited Metabolic Disorders Unit (T.G.), University Hospitals Birmingham, United Kingdom.

Marianna Fontana (M)

Royal Free London NHS Foundation Trust and University College London, United Kingdom (T.K., U.R., M.F., D.H.).

Richard P Steeds (RP)

Cardiology Department (R.V., S.B., R.P.S.), University Hospitals Birmingham, United Kingdom.

Derralynn Hughes (D)

Royal Free London NHS Foundation Trust and University College London, United Kingdom (T.K., U.R., M.F., D.H.).

Rebecca Kozor (R)

Sydney Medical School, University of Sydney, Australia (R.K.).

James C Moon (JC)

Institute of Cardiovascular Science, University College London, United Kingdom (J.B.A., S.N., M.A., K.K., G.C., T.K., J.C.M.).
Cardiac Imaging Department, Barts Heart Centre, St Bartholomew's Hospital, London, United Kingdom (J.B.A., S.N., H.B., M.A., K.K., J.C.M.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH